Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
300677.SZ Stock Summary
Top 10 Correlated ETFs
300677.SZ
In the News
300677.SZ Financial details
Company Rating
Buy
Market Cap
18.07B
Income
1.7B
Revenue
8.18B
Book val./share
28.59
Cash/share
13.55
Dividend
0.75
Dividend %
2.74%
Employees
9.12K
Optionable
No
Shortable
Yes
Earnings
22 Apr 2022
P/E
23.88
Forward P/E
-
PEG
-3.06
P/S
2.92
P/B
0.96
P/C
2.02
P/FCF
-32.07
Quick Ratio
4.15
Current Ratio
5.11
Debt / Equity
0.26
LT Debt / Equity
0
-
-
EPS (TTM)
3.21
EPS next Y
-
EPS next Q
-
EPS this Y
-7.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
103.58%
Revenue last 5Y
56.13%
Revenue Q/Q
1.32%
EPS Q/Q
-25.92%
-
-
-
-
SMA20
-6.1%
SMA50
15.46%
SMA100
14.45%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
4%
ROC
0.05%
Gross Margin
14%
Oper. Margin
16%
Profit Margin
12%
Payout
67%
Shs Outstand
659.77M
Shs Float
423.04M
-
-
-
-
Target Price
-
52W Range
18.68-40.25
52W High
-31.5%
52W Low
+52.22%
RSI
66.66
Rel Volume
2.3
Avg Volume
11.77M
Volume
27.07M
Perf Week
13.08%
Perf Month
3.24%
Perf Quarter
42.41%
Perf Half Y
36.32%
-
-
-
-
Beta
0.87799
-
-
Volatility
1.1%, 1.07%
Prev Close
8.56%
Price
27.4
Change
9.78%
300677.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 4.69 | 4.31 | 4.72 | 28.94 | 29.73 | |
Net income per share | 0.39 | 0.41 | 0.4 | 14.65 | 13.6 | |
Operating cash flow per share | 0.66 | 0.42 | 0.75 | 17.96 | 15.89 | |
Free cash flow per share | 0.09 | -0.28 | -0.47 | 11.92 | 5.92 | |
Cash per share | 0.77 | 1.96 | 1.98 | 13.36 | 15.15 | |
Book value per share | 2.92 | 2.9 | 3.35 | 19.54 | 29.05 | |
Tangible book value per share | 2.83 | 2.69 | 2.96 | 19.02 | 28.36 | |
Share holders equity per share | 2.92 | 2.9 | 3.35 | 19.54 | 29.05 | |
Interest debt per share | 0.71 | 1.89 | 2.37 | 0.63 | 0.57 | |
Market cap | 3.41B | 2.25B | 2.58B | 42.71B | 25.68B | |
Enterprise value | 3.38B | 2.21B | 2.98B | 37.99B | 20.97B | |
P/E ratio | 23.52 | 12.56 | 14.45 | 6.1 | 3.46 | |
Price to sales ratio | 1.95 | 1.19 | 1.24 | 3.09 | 1.58 | |
POCF ratio | 13.79 | 12.12 | 7.82 | 4.97 | 2.96 | |
PFCF ratio | 96.78 | -18.34 | -12.46 | 7.49 | 7.93 | |
P/B Ratio | 3.14 | 1.77 | 1.74 | 4.57 | 1.62 | |
PTB ratio | 3.14 | 1.77 | 1.74 | 4.57 | 1.62 | |
EV to sales | 1.93 | 1.17 | 1.43 | 2.75 | 1.29 | |
Enterprise value over EBITDA | 13.95 | 7.35 | 9.21 | 4.46 | 2.33 | |
EV to operating cash flow | 13.64 | 11.89 | 9.03 | 4.42 | 2.42 | |
EV to free cash flow | 95.74 | -17.99 | -14.4 | 6.66 | 6.48 | |
Earnings yield | 0.04 | 0.08 | 0.07 | 0.16 | 0.29 | |
Free cash flow yield | 0.01 | -0.05 | -0.08 | 0.13 | 0.13 | |
Debt to equity | 0.52 | 0.9 | 1.01 | 0.37 | 0.28 | |
Debt to assets | 0.34 | 0.47 | 0.5 | 0.27 | 0.22 | |
Net debt to EBITDA | -0.15 | -0.14 | 1.24 | -0.56 | -0.52 | |
Current ratio | 1.62 | 1.34 | 1.78 | 3.82 | 5.17 | |
Interest coverage | 14.87 | 13.65 | 8 | 405.75 | 493.53 | |
Income quality | 1.71 | 1.04 | 1.85 | 1.23 | 1.17 | |
Dividend Yield | 0 | 0.01 | 0.02 | 0 | 0.04 | |
Payout ratio | 0.1 | 0.16 | 0.31 | 0.02 | 0.14 | |
Sales general and administrative to revenue | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | |
Intangibles to total assets | 0.02 | 0.04 | 0.07 | 0.03 | 0.03 | |
Capex to operating cash flow | -0.86 | -1.66 | -1.63 | -0.34 | -0.63 | |
Capex to revenue | -0.12 | -0.16 | -0.26 | -0.21 | -0.34 | |
Capex to depreciation | -3.25 | -3.88 | -5.82 | -20.63 | -14.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.05 | 5.17 | 5.52 | 80.26 | 94.28 | |
ROIC | 0.21 | 0.34 | 0.13 | 3.52 | 0.8 | |
Return on tangible assets | 0.09 | 0.08 | 0.06 | 0.56 | 0.37 | |
Graham Net | -0.54 | -0.43 | -1.14 | 6.95 | 7.9 | |
Working capital | 328.26M | 367.74M | 676.5M | 6.28B | 8.68B | |
Tangible asset value | 1.06B | 1.18B | 1.31B | 9.09B | 15.49B | |
Net current asset value | 284.15M | 289.09M | 53.99M | 5.02B | 6.26B | |
Invested capital | 0.23 | 0.64 | 0.69 | 0.03 | 0.02 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 217.05M | 220.06M | 257.43M | 576.94M | 1.05B | |
Average inventory | 151.8M | 184.71M | 220.2M | 540.36M | 963.22M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 61.94 | 55.78 | 69.67 | 72.92 | 72.25 | |
Days of inventory on hand | 45.07 | 53.22 | 54.57 | 72.18 | 63 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 5.89 | 6.54 | 5.24 | 5.01 | 5.05 | |
Inventory turnover | 8.1 | 6.86 | 6.69 | 5.06 | 5.79 | |
ROE | 0.13 | 0.14 | 0.12 | 0.75 | 0.47 | |
Capex per share | -0.57 | -0.7 | -1.22 | -6.04 | -9.96 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-06-30 | 2021-09-30 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 7.64 | 5.76 | 4.11 | 2.61 | 2.64 | |
Net income per share | 4.15 | 2.06 | 0.15 | 0.57 | 0.42 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 3.52 | 0.64 | -0.45 | -0.59 | 0.03 | |
Cash per share | 16.57 | 17.06 | 14.53 | 14.07 | 13.55 | |
Book value per share | 27.74 | 29.8 | 28.67 | 28.44 | 28.59 | |
Tangible book value per share | 27.01 | 29.05 | 27.95 | 27.69 | 27.97 | |
Share holders equity per share | 27.74 | 29.8 | 28.67 | 28.44 | 28.59 | |
Interest debt per share | 1 | 1.15 | 1.09 | 1.62 | 0.92 | |
Market cap | 34.89B | 24.59B | 20.92B | 14.12B | 11.09B | |
Enterprise value | 28B | 19.69B | 16.7B | 9.87B | 5.26B | |
P/E ratio | 4.07 | 5.78 | 62.63 | 11.07 | 11.74 | |
Price to sales ratio | 8.86 | 8.27 | 9.14 | 9.72 | 7.54 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 19.19 | 74.68 | -83.53 | -42.65 | 620.88 | |
P/B Ratio | 2.44 | 1.6 | 1.31 | 0.89 | 0.7 | |
PTB ratio | 2.44 | 1.6 | 1.31 | 0.89 | 0.7 | |
EV to sales | 7.11 | 6.63 | 7.3 | 6.8 | 3.57 | |
Enterprise value over EBITDA | 11.08 | 17.51 | 146.53 | 23.41 | 16.06 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 15.4 | 59.82 | -66.68 | -29.83 | 294.47 | |
Earnings yield | 0.06 | 0.04 | 0 | 0.02 | 0.02 | |
Free cash flow yield | 0.05 | 0.01 | -0.01 | -0.02 | 0 | |
Debt to equity | 0.32 | 0.31 | 0.27 | 0.3 | 0.26 | |
Debt to assets | 0.24 | 0.23 | 0.21 | 0.23 | 0.2 | |
Net debt to EBITDA | -2.73 | -4.35 | -37.02 | -10.07 | -17.8 | |
Current ratio | 5.33 | 5.22 | 5.55 | 4.59 | 5.11 | |
Interest coverage | 771.07 | 255.07 | 21.44 | 61.29 | 54.85 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0.03 | 0 | 0 | 0.03 | 0 | |
Payout ratio | 0.49 | 0.01 | 0.04 | 1.31 | 0.03 | |
Sales general and administrative to revenue | 0 | 0.09 | 0.05 | -0.02 | 0.17 | |
Research and developement to revenue | 0.02 | 0.03 | 0.03 | 0.05 | 0.04 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.45 | -0.43 | -0.29 | -0.47 | -0.34 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 50.91 | 37.18 | 9.84 | 19.15 | 16.52 | |
ROIC | 0.64 | 0.13 | 0.01 | 0.03 | 0.03 | |
Return on tangible assets | 0.12 | 0.05 | 0 | 0.02 | 0.01 | |
Graham Net | 8.52 | 8.8 | 7.54 | 6.66 | 6.92 | |
Working capital | 8.99B | 9.32B | 8.56B | 7.81B | 7.47B | |
Tangible asset value | 13.94B | 14.99B | 15.55B | 15.41B | 15.57B | |
Net current asset value | 6.47B | 6.76B | 6.09B | 5.27B | 5.15B | |
Invested capital | 0.04 | 0.04 | 0.04 | 0.06 | 0.03 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 920.34M | 1.07B | 0 | 948.48M | 816.47M | |
Average inventory | 996.2M | 954.99M | 0 | 1.05B | 1.03B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 78.12 | 66.19 | 47.05 | 68.22 | 46.38 | |
Days of inventory on hand | 69.63 | 59.22 | 44.47 | 87.33 | 57.86 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.15 | 1.36 | 1.91 | 1.32 | 1.94 | |
Inventory turnover | 1.29 | 1.52 | 2.02 | 1.03 | 1.56 | |
ROE | 0.15 | 0.07 | 0.01 | 0.02 | 0.01 | |
Capex per share | -3.47 | -2.46 | -1.2 | -1.23 | -0.91 |
300677.SZ Frequently Asked Questions
What is Intco Medical Technology Co., Ltd. stock symbol ?
Intco Medical Technology Co., Ltd. is a CN stock and trading under the symbol 300677.SZ
What is Intco Medical Technology Co., Ltd. stock quote today ?
Intco Medical Technology Co., Ltd. stock price is $27.4 today.
Is Intco Medical Technology Co., Ltd. stock public?
Yes, Intco Medical Technology Co., Ltd. is a publicly traded company.